Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
4
×
fda
indiana blog main
4
×
indiana top stories
life sciences
national blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
biotech
calcitonin gene-related peptide
migraine
teva pharmaceutical
alder biopharmaceutical
alector
alkermes
allergan
american academy of neurology
What
new
4
×
drug
fda
approval
approved
class
migraine
won
announced
arguments
big
bio
biopharma
cancer
commercialized
companies
competitors
congress
congressional
crispr
decades
decision
deeper
developed
dna
drugs
eli
executives
feud
fingerprint
genetic
going
group
headache
isn’t
known
late
later
lilly
make
Language
Current search:
drugs
×
new
×
" indiana blog main "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines